Amy Spoering

Dr. Spoering is responsible for the development and evaluation of new methodologies and technologies at NovoBiotic Pharmaceuticals. She also supervises the fermentation facility including the production of teixobactin for research purposes. Her doctoral research investigated the molecular mechanisms of bacterial tolerance to antibiotics.